TEDCO CEO Troy LeMaile-Stovall believes the growth of the life sciences ecosystem in Maryland requires a greater sense of cohesion.
COVID-19 has created significant challenges for the Venture Capital (VC) market and life science companies seeking funding during the pandemic. While the pandemic has undoubtedly added a new layer of risk to an inherently risky field, the fundamentals for what makes a company attractive to a VC have remained steady.
Griffin St Louis Joins TEDCO as Program Manager, Maryland Innovation Initiative (MII)
Perhaps the single biggest challenge faced by startup entrepreneurs and early-stage life science companies is securing the necessary funding to fuel innovation and growth. The BioHealth Capital Region (BHCR) life science community as a whole faces a similar challenge when it comes to access to venture capital funding; this challenge has been noted by many BHCR thought leaders and well-documented in a host of BioBuzz stories.
New Director of TEDCO’s University Commercialization Fund Shares Vision for the Future The Maryland Innovation Initiative (MII) is the State’s premier $5.8M investment program for validating and commercializing University research [….]